Repotrectinib bulk supplier for pharma manufacturers

Repotrectinib 40mg, 160mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 40mg, 160mg

Reference Brands: Augtyro (USA)

Repotrectinib is a targeted cancer therapy used to treat ROS1-positive non-small cell lung cancer (NSCLC) and NTRK fusion-positive solid tumors. It works as a tyrosine kinase inhibitor, blocking key enzymes that promote tumor growth and survival. Available as oral capsules in strengths of 40 mg and 160 mg, Repotrectinib is designed for patients with advanced or metastatic cancers who have limited treatment options.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Repotrectinib — third party manufacturing & bulk supply

Repotrectinib 40mg, 160mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Repotrectinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Repotrectinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Repotrectinib →

Back to Listing

Frequently Asked Questions

Repotrectinib is listed as Capsules in 40mg, 160mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Repotrectinib is referenced against Augtyro (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.